These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7315192)

  • 41. Neurotransmitter-related enzymes in senile dementia of the Alzheimer type.
    Davies P
    Brain Res; 1979 Aug; 171(2):319-27. PubMed ID: 37989
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Albumin and immunoglobulin in plasma and cerebrospinal fluid, and blood-cerebrospinal fluid barrier function in patients with dementia of Alzheimer type and multi-infarct dementia.
    Alafuzoff I; Adolfsson R; Bucht G; Winblad B
    J Neurol Sci; 1983; 60(3):465-72. PubMed ID: 6631444
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular isoform distribution and glycosylation of acetylcholinesterase are altered in brain and cerebrospinal fluid of patients with Alzheimer's disease.
    Sáez-Valero J; Sberna G; McLean CA; Small DH
    J Neurochem; 1999 Apr; 72(4):1600-8. PubMed ID: 10098867
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cerebrospinal fluid levels of biomarkers and activity of acetylcholinesterase (AChE) and butyrylcholinesterase in AD patients before and after treatment with different AChE inhibitors.
    Parnetti L; Amici S; Lanari A; Romani C; Antognelli C; Andreasen N; Minthon L; Davidsson P; Pottel H; Blennow K; Gallai V
    Neurol Sci; 2002 Sep; 23 Suppl 2():S95-6. PubMed ID: 12548360
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Peptide histidine methionine in cerebrospinal fluid of patients with senile dementia of the Alzheimer type.
    Yasuda M; Minamitani N; Maeda K
    Jpn J Psychiatry Neurol; 1993 Mar; 47(1):85-90. PubMed ID: 8105129
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Increased acetylcholinesterase activity in the CSF of Alzheimer patients carrying apolipoprotein epsilon4 allele.
    Soininen H; Lehtovirta M; Helisalmi S; Linnaranta K; Heinonen O; Riekkinen P
    Neuroreport; 1995 Dec; 6(18):2518-20. PubMed ID: 8741753
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-lasting acetylcholinesterase splice variations in anticholinesterase-treated Alzheimer's disease patients.
    Darreh-Shori T; Hellström-Lindahl E; Flores-Flores C; Guan ZZ; Soreq H; Nordberg A
    J Neurochem; 2004 Mar; 88(5):1102-13. PubMed ID: 15009666
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differential increase in cerebrospinal fluid-acetylcholinesterase after treatment with acetylcholinesterase inhibitors in patients with Alzheimer's disease.
    Davidsson P; Blennow K; Andreasen N; Eriksson B; Minthon L; Hesse C
    Neurosci Lett; 2001 Mar; 300(3):157-60. PubMed ID: 11226635
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Glycosylation of acetylcholinesterase and butyrylcholinesterase changes as a function of the duration of Alzheimer's disease.
    Sáez-Valero J; Fodero LR; Sjögren M; Andreasen N; Amici S; Gallai V; Vanderstichele H; Vanmechelen E; Parnetti L; Blennow K; Small DH
    J Neurosci Res; 2003 May; 72(4):520-6. PubMed ID: 12704813
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cerebrospinal fluid acetylcholinesterase changes after treatment with donepezil in patients with Alzheimer's disease.
    García-Ayllón MS; Silveyra MX; Andreasen N; Brimijoin S; Blennow K; Sáez-Valero J
    J Neurochem; 2007 Jun; 101(6):1701-11. PubMed ID: 17326766
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Demonstration of CSF gamma-globulin banding in presenile dementia.
    Williams A; Papadopoulos N; Chase TN
    Neurology; 1980 Aug; 30(8):882-4. PubMed ID: 6158020
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Changes in CSF acetyl- and butyrylcholinesterase activity after long-term treatment with AChE inhibitors in Alzheimer's disease.
    Parnetti L; Chiasserini D; Andreasson U; Ohlson M; Hüls C; Zetterberg H; Minthon L; Wallin AK; Andreasen N; Talesa VN; Blennow K
    Acta Neurol Scand; 2011 Aug; 124(2):122-9. PubMed ID: 20880294
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reduced prealbumin (transthyretin) in CSF of severely demented patients with Alzheimer's disease.
    Riisøen H
    Acta Neurol Scand; 1988 Dec; 78(6):455-9. PubMed ID: 3223231
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cerebrospinal fluid neurochemistry in the myoclonic subtype of Alzheimer's disease.
    Kaye JA; May C; Atack JR; Daly E; Sweeney DL; Beal MF; Kaufman S; Milstien S; Friedland RP; Rapoport SI
    Ann Neurol; 1988 Nov; 24(5):647-50. PubMed ID: 2462403
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular forms of cholinesterases in CSF of Alzheimer's disease/senile dementia of Alzheimer type patients and matched neurological controls.
    Bisso GM; Masullo C; Michalek H; Silveri MC; Pocchiari M
    Life Sci; 1986 Feb; 38(6):561-7. PubMed ID: 3945178
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cerebrospinal fluid acetylcholinesterase and choline measurements in Huntington's disease.
    Manyam BV; Giacobini E; Colliver JA
    J Neurol; 1990 Aug; 237(5):281-4. PubMed ID: 2146369
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Soluble amyloid beta-protein in the cerebrospinal fluid from patients with Alzheimer's disease, vascular dementia and controls.
    Pirttilä T; Kim KS; Mehta PD; Frey H; Wisniewski HM
    J Neurol Sci; 1994 Dec; 127(1):90-5. PubMed ID: 7699397
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Brain and cerebrospinal fluid cholinesterases in Alzheimer's disease, Parkinson's disease and aging. A critical review of clinical and experimental studies.
    Sirviö J; Riekkinen PJ
    J Neural Transm Park Dis Dement Sect; 1992; 4():337-58. PubMed ID: 1388703
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Decreased level of beta-endorphin-like immunoreactivity in cerebrospinal fluid of patients with senile dementia of Alzheimer type.
    Kaiya H; Tanaka T; Takeuchi K; Morita K; Adachi S; Shirakawa H; Ueki H; Namba M
    Life Sci; 1983 Sep; 33(11):1039-43. PubMed ID: 6310293
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cerebrospinal fluid beta-amyloid 42 is reduced before the onset of sporadic dementia: a population-based study in 85-year-olds.
    Skoog I; Davidsson P; Aevarsson O; Vanderstichele H; Vanmechelen E; Blennow K
    Dement Geriatr Cogn Disord; 2003; 15(3):169-76. PubMed ID: 12584433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.